Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ephedrine and unheralded sudden cardiac death

15.10.2004


New study links possible role of ephedrine in the sudden cardiac death of people with asymptomatic heart disease



Each year 80 to 100,000 Americans die suddenly from heart attacks without ever having had any symptoms of heart disease. In some cases, the victims of these unheralded sudden cardiac deaths had been taking dietary supplements containing ephedrine. In a new study in the Oct. 26, 2004 issue of the Journal of the American College of Cardiology, researchers show how ephedrine can cause sudden cardiac death in an animal model of asymptomatic heart disease.

"For our experiment, we went to the local health food store, bought ephedrine supplements and gave our animals the dose recommended on the label," said Philip B. Adamson, M.D., associate professor in the department of physiology and the department of medicine - cardiovascular diseases at the University of Oklahoma Health Sciences Center in Oklahoma City, Okla. and lead author of the study. "Ephedrine mimics the sympathetic nervous system, the part of the nervous system that makes the heart beat stronger and faster. In past experiments on obese, otherwise healthy individuals ephedrine did not raise their heart rates when they were either at rest or exercising." Dr. Adamson spoke today at the American Medical Association’s 23rd Annual Science Reporters Conference in Washington D.C.


"When we gave healthy animals ephedrine, we found exactly the same thing," Dr. Adamson said. "But the moment they developed a blockage in their heart artery, which we are able to cause reversibly, their heart rates went through the roof. It was the response to ischemia, a condition where there is a blockage of the heart’s blood supply that was exaggerated by ephedrine."

"In ischemic heart disease, the blood supply to the heart becomes constricted, causing damage to the heart muscle and heart disease. However, sometimes the condition develops without any symptoms, leading to a sudden heart attack. Death can be the first symptom people with ischemic heart disease experience," Dr. Adamson said. "We wanted to determine how ephedrine, taken as directed, might cause someone with ischemic heart disease to have a potentially fatal heart attack." "Ephedrine looks benign when you look at its effects on normal heart rates, but when there is a blockage, boom, ephedrine causes a potentially lethal arrhythmia," Dr. Adamson said. "The heart starts beating so fast, it can no longer pump blood."

Dr. Adamson used an animal model of ischemic heart disease. Of the 15 animals given ephedrine, nine had increased ventricular arrhythmias (a dangerous and wild beating of the heart) and four had ventricular fibrillation (VF, an extreme arrhythmia where the heart can no longer pump). One of the four animals with VF could not be resuscitated.

Ephedrine was marketed for many years as an aid to weight loss and an enhancer of athletic performance, but has never been systematically studied, although it has been implicated in hundreds of adverse reactions. "As the cardiologist for the university’s athletic department, I was interested in researching ephedrine’s effects on the body," Dr. Adamson said. "I was amazed at the number of student athletes taking ephedrine and other supplements without really any idea what they did."

"We have been studying how the sympathetic nervous system destabilizes the heart’s electrical system and increases the risk of arrhythmia for some time. We didn’t expect such a dramatic response to ephedrine," he said. "The sympathetic nervous system was super-powered by the ephedrine, greatly increasing the risk of causing an instability of the electro-physiology of the heart."

"This study certainly supports the FDA’s decision to ban ephedrine from dietary supplements (the ban went into effect in February 2004)," Dr. Adamson said. "I hope it will also offer us additional insights into the nature and causes of unheralded sudden death."

Christine M. Feheley | EurekAlert!
Further information:
http://www.acc.org

More articles from Studies and Analyses:

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Disarray in the brain
18.12.2017 | Universität zu Lübeck

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>